A detailed history of Elwood & Goetz Wealth Advisory Group, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Elwood & Goetz Wealth Advisory Group, LLC holds 534 shares of LLY stock, worth $424,887. This represents 0.12% of its overall portfolio holdings.

Number of Shares
534
Previous 534 -0.0%
Holding current value
$424,887
Previous $483,000 2.07%
% of portfolio
0.12%
Previous 0.14%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 18, 2024

BUY
$525.19 - $619.13 $18,906 - $22,288
36 Added 7.23%
534 $311,000
Q3 2023

Oct 19, 2023

BUY
$434.7 - $599.3 $216,480 - $298,451
498 New
498 $267,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Elwood & Goetz Wealth Advisory Group, LLC Portfolio

Follow Elwood & Goetz Wealth Advisory Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Elwood & Goetz Wealth Advisory Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Elwood & Goetz Wealth Advisory Group, LLC with notifications on news.